Virtus ETF Advisers LLC Aprea Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 10, 2021	SELL	$4.05 - $5.5 $42,338 - $57,497	-10,454 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.73 - $8.15 $912 - $1,572	193 Added 1.88%	10,454 $53,000
Q4 2020 Feb 12, 2021	BUY	$4.92 - $30.67 $1,047 - $6,532	213 Added 2.12%	10,261 $50,000
Q3 2020 Nov 13, 2020	SELL	$21.66 - $38.86 $30,042 - $53,898	-1,387 Reduced 12.13%	10,048 $242,000
Q2 2020 Aug 05, 2020	BUY	$25.47 - $39.69 $291,249 - $453,855	11,435 New	11,435 $443,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,849
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.